CIK 0001398733
- Non-accelerated filer
- Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208623253
- Phone
- +1 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $297,289
- in 4 filings, $297K under 10b5-1 plans
Net −$197,958. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | TOTH A ERNEST JR Chief Financial Officer | Shares withheld for taxes | −92,652 | $4.18 | $387K | 283,460 |
| 2026-03-10 | TOTH A ERNEST JR Chief Financial Officer | Sale | −58,254 | $4.17 | $243K | 376,112 |
| 2026-03-09 | TOTH A ERNEST JR Chief Financial Officer | Grant or award | +95,000 | 434,366 | ||
| 2026-03-09 | TOTH A ERNEST JR Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2025-03-09 | TOTH A ERNEST JR Chief Financial Officer | Shares withheld for taxes | −8,736 | $2.65 | $23K | 339,366 |
| 2025-03-07 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Performance Stock Units | +82,500 | 82,500 | ||
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Grant or award | +110,000 | 358,295 | ||
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Shares withheld for taxes | −10,193 | $2.65 | $27K | 348,102 |
| 2025-03-07 | TOTH A ERNEST JR Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2024-03-09 | TOTH A ERNEST JR SVP, Chief Financial Officer | Shares withheld for taxes | −11,705 | $4.88 | $57K | 248,295 |
| 2024-03-07 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award | +120,000 | 260,000 | ||
| 2024-03-07 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2023-08-09 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Performance Stock Units | +70,000 | 70,000 | ||
| 2023-05-05 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Performance Stock Units | +70,000 | 70,000 | ||
| 2023-03-09 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award | +140,000 | 140,000 | ||
| 2022-11-04 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-03-10 | TOTH A ERNEST JR Interim CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2021-06-15 | TOTH A ERNEST JR SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Purchase) | +120,000 | 120,000 | ||
| 2021-03-11 | TOTH A ERNEST JR Interim CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +2,500 | 2,500 |
Page 1 of 1 · 19 trades